A detailed history of Pine Bridge Investments, L.P. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 136,209 shares of CRL stock, worth $26.7 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
136,209
Previous 128,386 6.09%
Holding current value
$26.7 Million
Previous $26.5 Million 1.17%
% of portfolio
0.21%
Previous 0.22%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $1.47 Million - $1.92 Million
7,823 Added 6.09%
136,209 $26.8 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $928,135 - $1.21 Million
4,497 Added 3.63%
128,386 $26.5 Million
Q1 2024

May 14, 2024

BUY
$203.52 - $273.43 $4.78 Million - $6.43 Million
23,508 Added 23.42%
123,889 $33.6 Million
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $3.1 Million - $4.5 Million
18,849 Added 23.12%
100,381 $23.7 Million
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $1.42 Million - $1.58 Million
7,278 Added 9.8%
81,532 $16 Million
Q2 2023

Aug 11, 2023

SELL
$183.71 - $210.25 $448,619 - $513,430
-2,442 Reduced 3.18%
74,254 $15.6 Million
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $1.28 Million - $1.74 Million
6,676 Added 9.53%
76,696 $15.5 Million
Q4 2022

Feb 09, 2023

BUY
$197.11 - $250.07 $2.75 Million - $3.49 Million
13,958 Added 24.9%
70,020 $15.3 Million
Q3 2022

Nov 10, 2022

BUY
$182.44 - $250.54 $599,497 - $823,274
3,286 Added 6.23%
56,062 $11 Million
Q2 2022

Aug 05, 2022

BUY
$204.13 - $302.4 $345,796 - $512,265
1,694 Added 3.32%
52,776 $11.3 Million
Q1 2022

May 12, 2022

BUY
$255.51 - $362.11 $6.2 Million - $8.79 Million
24,267 Added 90.5%
51,082 $14.5 Million
Q4 2021

Feb 10, 2022

SELL
$351.38 - $448.68 $1.2 Million - $1.54 Million
-3,428 Reduced 11.33%
26,815 $10.1 Million
Q3 2021

Nov 09, 2021

SELL
$372.64 - $458.3 $7.89 Million - $9.7 Million
-21,169 Reduced 41.18%
30,243 $12.5 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $4.32 Million - $5.46 Million
14,700 Added 40.04%
51,412 $19 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $1.11 Million - $1.26 Million
-4,986 Reduced 11.96%
36,712 $9.17 Million
Q3 2020

Nov 13, 2020

BUY
$175.56 - $226.45 $1.21 Million - $1.57 Million
6,914 Added 19.88%
41,698 $9.44 Million
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $4.13 Million - $6.6 Million
34,784 New
34,784 $6.07 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.